Compare GLPI & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLPI | FMS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | Real Estate Investment Trusts | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.5B |
| IPO Year | 2013 | N/A |
| Metric | GLPI | FMS |
|---|---|---|
| Price | $43.79 | $24.44 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $51.95 | $30.00 |
| AVG Volume (30 Days) | ★ 2.8M | 579.5K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.50% | 2.57% |
| EPS Growth | ★ 2.79 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $1,594,752,000.00 | N/A |
| Revenue This Year | $9.17 | N/A |
| Revenue Next Year | $5.40 | $3.83 |
| P/E Ratio | $52.65 | ★ $15.62 |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $41.17 | $20.02 |
| 52 Week High | $49.95 | $27.64 |
| Indicator | GLPI | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 65.94 |
| Support Level | $42.45 | $22.47 |
| Resistance Level | $43.90 | $24.71 |
| Average True Range (ATR) | 0.86 | 0.31 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 33.48 | 95.66 |
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company also extends loans that produce fixed or variable returns, which may convert into leased rent upon project completion or stabilization. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.